INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 240 filers reported holding INSMED INC in Q3 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $665,093 | +84.0% | 31,521 | +48.6% | 0.09% | +85.7% |
| Q1 2023 | $361,545 | -45.8% | 21,205 | -36.5% | 0.05% | -54.6% |
| Q4 2022 | $667,132 | -65.1% | 33,390 | -62.4% | 0.11% | -62.6% |
| Q3 2022 | $1,911,000 | +184.4% | 88,697 | +210.1% | 0.29% | +398.3% |
| Q1 2022 | $672,000 | -12.7% | 28,601 | -32.5% | 0.06% | -45.3% |
| Q4 2015 | $770,000 | -0.9% | 42,403 | +1.3% | 0.11% | +523.5% |
| Q3 2015 | $777,000 | +66.4% | 41,845 | +119.0% | 0.02% | +41.7% |
| Q2 2015 | $467,000 | +117.2% | 19,108 | +15.8% | 0.01% | +100.0% |
| Q3 2014 | $215,000 | -76.7% | 16,504 | -72.1% | 0.01% | -76.0% |
| Q3 2013 | $924,000 | – | 59,193 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |